Troxerutin prices in China have stabilized during the first half of September 2025 following the decline in August, impacted by low inventory levels, as well as increasing international demand and expectations of seasonal winter procurement. The Troxerutin price during August declined created by Rutin’s supply backlog, adverse weather for harvesting, and a 1.13% monthly devaluation of the USD against the yuan, which allowed suppliers’ inventory to accumulate, while sales dropped, leading sellers to discount the price of Troxerutin during the month of August. Weak demand from the pharmaceutical and health industries, along with other factors such as tariffs, reduced export orders, worsening the imbalance. In September, Troxerutin demand returned to mild level as inventory position improved, being more aligned with international demand levels and seasonal uptick in downstream production. Looking ahead, market sources speculate, that there will be a slight price increase, as demand improved with stronger buying patterns and positive market conditions such as higher imports of Troxerutin and boosted overall US-Chinese trade conditions. Sellers may lean towards bullish attitudes as volumes have improved, and Troxerutin market fundamentals proposed supportive sentiment.
In the first half of September 2025, Troxerutin prices in China stabilized after a big drop in August due to inventory clearance, low inventory and rising international demand. The stabilization of Troxerutin prices reflects the change of market dynamics, with growing demand from both domestic and international market, especially as the winter production season is approaching, boosting the seasonal demand of Troxerutin. This surge in demand plus the improved market sentiment has made the supply and demand of Troxerutin in China more balanced.
In August 2025, Troxerutin prices in China dropped significantly due to falling feedstock cost, especially the gradual decline of Rutin price caused by oversupply and bad weather. These factors reduced the production cost, so Troxerutin suppliers adjusted the price downward to be competitive. The increasing production led to the surplus stock in suppliers’ inventory, and to manage the excess volume, suppliers offered discounts, further pressured Troxerutin prices. The 1.13% depreciation of US dollar against Chinese yuan also influenced the pricing strategy to maintain the export competitiveness. Despite the smooth logistics and trade flow, the overseas buying interest for Troxerutin weakened due to trade barriers and prior stockpiling, and the bearish trend of Troxerutin price continued in August.
In August, the demand of Troxerutin in China was weak, mainly due to the reduced consumption from pharmaceutical and healthcare industry. The high inventory of importers reduced the need of new Troxerutin procurement, and the export activity slowed down as the overseas orders decreased. The 90-day extension of the tariff truce between Washington and Beijing further weakened the forward buying interest from US importers, and the supply and demand of Troxerutin was imbalanced. The domestic offtake was slow, the export was restrained and the stock was ample, so the market was quiet and the price of Troxerutin was under pressure.
In the first half of September, the Troxerutin market started to recover. Inventory clearance in August reduced stock levels and brought supply more in line with demand. International demand for Troxerutin especially from pharma sectors is supporting price stability. Start of winter production season is also driving demand as industries are ramping up Troxerutin consumption to meet seasonal needs. Improved buyer sentiment and good trade conditions are also contributing to a better outlook for Troxerutin.
Market expects a slight price increase in second half of September 2025 as buying activity picks up. Order volumes for Troxerutin will be the same as last month but with higher transaction volumes. Good trade conditions and improved buyer sentiment will boost import orders and keep Troxerutin market fundamentals strong. Sellers will be bullish as transaction volumes will be healthy and demand will be steady from both domestic and international markets. Combination of seasonal demand growth and lower inventory will be positive for Troxerutin market in the coming weeks.
